{"title":"Quercetin attenuates pentylenetetrazol-induced seizures in chicks through antioxidant and anti-inflammatory pathways.","authors":"Suleiman Dawood Suleiman, Jian Salam Hasan, Karwan Idrees Jarjees, Aziza Raof Haji","doi":"10.5455/javar.2025.l963","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study examines the neuroprotective and anticonvulsant effects of quercetin on pentylenetetrazol (PTZ)-induced convulsive seizures in chicks.</p><p><strong>Materials and methods: </strong>Sixty Ross broiler chicks were randomly assigned to six groups: a negative control, a positive control treated with PTZ at 80 mg/kg, a diazepam-treated group (5 mg/kg), and three quercetin-treated groups receiving 50, 100, and 200 mg/kg orally for six consecutive days, respectively. Two hours after the final dose, PTZ was administered to groups 3-6 to induce seizures. The onset of convulsions and mortality rates were recorded over a period of 3 h. Brain tissue was collected to determine biochemical parameters, malondialdehyde (MDA), total antioxidant capacity (TAO-C), interleukin-1β (IL-1β), and tumor necrosis factor-α (<i>TNF-</i> <i>α</i>).</p><p><strong>Results: </strong>The delay in the onset of convulsions and survival improvement were found in quercetin pretreatment, in a dose-dependent manner. The highly significant survival was found at 200 mg/kg (<i>p <</i> 0.001), and moderately at 50 and 100 mg/kg (<i>p <</i> 0.05). MDA (<i>p <</i> 0.05) and <i>TNF-</i> <i>α</i> (<i>p <</i> 0.01) levels were significantly decreased at all doses. TAO-C levels were significantly elevated, while IL-1β levels declined at 200 mg/kg (<i>p <</i> 0.05).</p><p><strong>Conclusion: </strong>Quercetin pretreatment at 200 mg/kg showed antioxidant and anti-inflammatory potential against PTZ-induced convulsive seizure as a preventive therapy for epilepsy management.</p>","PeriodicalId":14892,"journal":{"name":"Journal of Advanced Veterinary and Animal Research","volume":"12 3","pages":"1037-1044"},"PeriodicalIF":1.9000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665323/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Veterinary and Animal Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/javar.2025.l963","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"AGRICULTURE, DAIRY & ANIMAL SCIENCE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study examines the neuroprotective and anticonvulsant effects of quercetin on pentylenetetrazol (PTZ)-induced convulsive seizures in chicks.
Materials and methods: Sixty Ross broiler chicks were randomly assigned to six groups: a negative control, a positive control treated with PTZ at 80 mg/kg, a diazepam-treated group (5 mg/kg), and three quercetin-treated groups receiving 50, 100, and 200 mg/kg orally for six consecutive days, respectively. Two hours after the final dose, PTZ was administered to groups 3-6 to induce seizures. The onset of convulsions and mortality rates were recorded over a period of 3 h. Brain tissue was collected to determine biochemical parameters, malondialdehyde (MDA), total antioxidant capacity (TAO-C), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α).
Results: The delay in the onset of convulsions and survival improvement were found in quercetin pretreatment, in a dose-dependent manner. The highly significant survival was found at 200 mg/kg (p < 0.001), and moderately at 50 and 100 mg/kg (p < 0.05). MDA (p < 0.05) and TNF-α (p < 0.01) levels were significantly decreased at all doses. TAO-C levels were significantly elevated, while IL-1β levels declined at 200 mg/kg (p < 0.05).
Conclusion: Quercetin pretreatment at 200 mg/kg showed antioxidant and anti-inflammatory potential against PTZ-induced convulsive seizure as a preventive therapy for epilepsy management.